NILO, ANNACARMEN
 Distribuzione geografica
Continente #
NA - Nord America 1.577
AS - Asia 1.445
EU - Europa 723
SA - Sud America 269
AF - Africa 44
OC - Oceania 4
Totale 4.062
Nazione #
US - Stati Uniti d'America 1.527
SG - Singapore 753
IT - Italia 255
CN - Cina 208
BR - Brasile 202
HK - Hong Kong 147
VN - Vietnam 139
DE - Germania 97
RU - Federazione Russa 84
FR - Francia 68
IN - India 49
GB - Regno Unito 41
FI - Finlandia 37
AR - Argentina 30
NL - Olanda 25
KR - Corea 24
BD - Bangladesh 22
CA - Canada 21
IE - Irlanda 20
UA - Ucraina 19
MX - Messico 18
AT - Austria 17
TR - Turchia 14
ZA - Sudafrica 14
JP - Giappone 12
IQ - Iraq 11
TG - Togo 11
ES - Italia 10
LT - Lituania 10
PL - Polonia 10
EC - Ecuador 8
IL - Israele 8
SA - Arabia Saudita 8
BE - Belgio 7
PE - Perù 7
SE - Svezia 7
UZ - Uzbekistan 7
PY - Paraguay 6
CL - Cile 5
MA - Marocco 5
PK - Pakistan 5
AE - Emirati Arabi Uniti 4
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
EG - Egitto 4
JO - Giordania 4
NP - Nepal 4
AU - Australia 3
CO - Colombia 3
DZ - Algeria 3
ID - Indonesia 3
IR - Iran 3
KG - Kirghizistan 3
KZ - Kazakistan 3
VE - Venezuela 3
AM - Armenia 2
AZ - Azerbaigian 2
BY - Bielorussia 2
CH - Svizzera 2
DK - Danimarca 2
GR - Grecia 2
HN - Honduras 2
KE - Kenya 2
SN - Senegal 2
SV - El Salvador 2
TN - Tunisia 2
UY - Uruguay 2
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CR - Costa Rica 1
CY - Cipro 1
GY - Guiana 1
HR - Croazia 1
KH - Cambogia 1
LB - Libano 1
LV - Lettonia 1
MY - Malesia 1
NC - Nuova Caledonia 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
RS - Serbia 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TJ - Tagikistan 1
Totale 4.062
Città #
Singapore 353
Ashburn 219
Hong Kong 146
Chandler 121
San Jose 110
Beijing 88
Fairfield 66
Los Angeles 55
Boardman 51
Munich 49
Lauterbourg 47
Ho Chi Minh City 46
Woodbridge 45
Seattle 44
Venezia 36
Dallas 32
New York 31
Udine 29
Wilmington 29
Santa Clara 25
Hanoi 24
Hefei 24
Seoul 24
São Paulo 24
Houston 22
Cambridge 20
Dublin 20
Helsinki 20
Ann Arbor 19
Milan 19
Princeton 19
Tavagnacco 19
Buffalo 18
Redondo Beach 18
Ogden 17
Buenos Aires 16
Council Bluffs 16
Rome 16
Dong Ket 14
Amsterdam 13
Redmond 13
Frankfurt am Main 12
The Dalles 12
Codroipo 11
Hyderabad 11
Lappeenranta 11
Lomé 11
Mexico City 11
Nuremberg 11
Boston 10
Dearborn 10
Haiphong 10
Montreal 10
Tokyo 10
Düsseldorf 9
Jacksonville 9
London 9
Orem 9
Chennai 8
Chicago 8
Da Nang 8
Johannesburg 8
Manchester 8
Phoenix 8
Warsaw 8
Bologna 7
Brussels 7
Norwalk 7
Stockholm 7
Trieste 7
Vienna 7
Baghdad 6
Belo Horizonte 6
Guangzhou 6
Izmir 6
Poplar 6
Rio de Janeiro 6
San Francisco 6
Tashkent 6
Toronto 6
Turku 6
Atlanta 5
Dhaka 5
Lima 5
New Delhi 5
Villongo 5
Belluno 4
Brooklyn 4
Cairo 4
Curitiba 4
Grand Forks 4
Guarulhos 4
Mumbai 4
Portsmouth 4
Riyadh 4
Salvador 4
San Diego 4
Suzhou 4
Amman 3
Asunción 3
Totale 2.430
Nome #
ADMA as a possible marker of endothelial damage. A study in young asymptomatic patients with cerebral small vessel disease. 206
Timing use of novel anti-epileptic drugs: is earlier better? 145
Epilepsia partialis continua revealing idelalisib-associated PML-IRIS: clinical and pathological features 144
Risk Assessment by Pre-surgical Tractography in Left Hemisphere Low-Grade Gliomas 137
Pharmacokinetic and pharmacodynamic considerations for the clinical efficacy of perampanel in focal onset seizures 124
Investigational therapies for the treatment of narcolepsy 123
Epilepsy with eyelid myoclonias (Jeavons syndrome): an electro-clinical study of 40 patients from childhood to adulthood 116
Is the Asymmetric Dimethylarginine (ADMA) the Possible Molecule Driving Endothelial Damage in Young Asymptomatic Patients with Cerebral Small Vessel Disease? 115
Can epilepsy affect normal EEG variants? A comparative study between subjects with and without epilepsy 112
Benign EEG variants in the sleep–wake cycle: A prospective observational study using the 10–20 system and additional electrodes 111
Epilepsy and episodic ataxia type 2: family study and review of the literature 108
A comprehensive update on the ADMET considerations for α2δ calcium channel ligand medications for treating restless legs syndrome 100
Clinical and magnetic resonance study of a case of subacute sclerosing panencephalitis treated with ketogenic diet 100
Early Introduction of Cenobamate in Uncontrolled Focal Epilepsy: Insights from a Structured Controversy 93
Reply letter to "COVID-19 and Recurrent Status Epilepticus" 91
Current and emerging pharmaceutical strategies for the treatment and management of restless legs syndrome 89
Efficacy of Perampanel in Refractory and Super-Refractory Status Epilepticus with Suspected Inflammatory Etiology: A Case Series 87
Association of Mortality and Risk of Epilepsy With Type of Acute Symptomatic Seizure After Ischemic Stroke and an Updated Prognostic Model 85
Predictive factors of Status Epilepticus and its recurrence in patients with adult–onset seizures: A multicenter, long follow–up cohort study 85
Seizures, Epilepsy, and NORSE Secondary to Autoimmune Encephalitis: A Practical Guide for Clinicians 84
Intravenous brivaracetam in status epilepticus: A multicentric retrospective study in Italy 82
Post-Stroke Status Epilepticus: Time of Occurrence May Be the Difference? 82
Meningioma-Related Epilepsy: A Happy Ending? 81
Perampanel as add-on therapy in epilepsies with known etiology: A single center experience with long-term follow-up 80
Adjunctive Perampanel in Older Patients With Epilepsy: A Multicenter Study of Clinical Practice 77
Effect of Dexmedetomidine versus Propofol on Intraoperative Seizure Onset During Awake Craniotomy: A Retrospective Study 77
What’s behind drawing for an artist with left temporal lobe epilepsy? A multimodal neurophysiological study 77
HLA and immunological features of SARS-CoV-2-induced Guillain-Barré syndrome 76
Neurological disorders in COVID-19: a case of Acute Disseminated Encephalomyelitis in an adult patient 74
Recurrent Status Epilepticus and SARS-CoV-2 infection: the "perfect storm" 74
A real‐world comparison among third‐generation antiseizure medications: Results from the COMPARE study 74
Aging in multiple sclerosis: from childhood to old age, etiopathogenesis, and unmet needs: a narrative review 72
Prognostic factors in epilepsy with eyelid myoclonia (Jeavons syndrome) 70
Ischemic strokes in COVID-19: risk factors, obesity paradox, and distinction between trigger and causal association 70
Turning off the siren of the night: botulinum toxin for the treatment of nocturnal groaning. A case series 70
Erenumab Impact on Sleep Assessed With Questionnaires and Home-Polysomnography in Patients With Migraine: The ERESON Study 69
An “epileptic scent”: Olfactory auras in tumor-related epilepsy 69
A retrospective multicentric study on the effectiveness of intravenous brivaracetam in seizure clusters: Data from the Italian experience 68
Performing real time neuropsychological testing during awake craniotomy: are dexmedetomidine or propofol the same? A preliminary report 68
Brivaracetam as add‐on treatment in focal epilepsy: A real‐world time‐based analysis 68
New-onset status epilepticus in SARS-CoV-2 infection: a case series 65
Reader Response: Prolonged Unconsciousness Following Severe COVID-19 64
Ketogenic Diet Improves Sleep Quality and Daytime Sleepiness in Chronic Migraine: A Pilot Study 63
Evaluation and treatment approaches for neurological post-acute sequelae of COVID-19: A consensus statement and scoping review from the global COVID-19 neuro research coalition 61
Spikes/spike-waves time-locked to the flash frequency during intermittent light stimulation in Jeavons syndrome 60
Association of the Timing and Type of Acute Symptomatic Seizures With Poststroke Epilepsy and Mortality 57
Late epileptic seizures following cerebral venous thrombosis: a systematic review and meta-analysis 46
Implications for driving based on the risk of seizures after ischaemic stroke 35
Intraoperative Seizures in Glioma Surgery: Is It Really Only an Intraoperative Issue? 32
Pre- and Post-surgical Poor Seizure Control as Hallmark of Malignant Progression in Patients With Glioma? 28
Perampanel effects on seizures and sleep quality in people with epilepsy: A prospective multicenter study 25
Lacosamide is Associated with a Higher Treatment Persistence at 12 Months than Brivaracetam and Perampanel Despite Similar Efficacy 9
Comparative Effectiveness of Brivaracetam, Cenobamate, Lacosamide, and Perampanel in Focal Epilepsy 4
Totale 4.282
Categoria #
all - tutte 19.372
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.372


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202152 0 0 0 0 0 0 0 0 0 12 9 31
2021/2022190 8 8 55 8 1 2 7 7 1 20 54 19
2022/2023280 20 35 0 32 19 80 4 23 23 7 17 20
2023/2024253 20 16 12 8 14 8 2 38 30 52 8 45
2024/20251.161 43 62 126 39 60 33 98 68 169 85 154 224
2025/20261.956 217 319 153 216 318 163 244 66 137 123 0 0
Totale 4.282